NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 29, 2025 $2.33 +4.67% $2.23 X 95.33% 0
Aug 29, 2025 $2.30 +2.92% $2.23 X 97.08% 0
Aug 29, 2025 Bullish $2.23 X 0
Aug 26, 2025 $2.64 +4.43% $2.45 X 92.16% 0
Aug 26, 2025 $2.60 +2.77% $2.45 X 93.88% 0
Aug 26, 2025 Bullish $2.45 X 0
Aug 19, 2025 $2.38 -4.74% $2.60 X 91.59% 0
Aug 19, 2025 $2.43 -2.97% $2.60 X 93.30% 0
Aug 19, 2025 Bullish $2.60 V 1
Aug 18, 2025 $2.43 -4.79% $2.50 V 97.12% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE